Exclusive: GV-backed Prudentia launches with $7M to boost pharma dealmakingnews2025-01-08T13:00:09+00:00January 8th, 2025|Endpoints News|
Pfizer extends AI drug discovery pact with PostEra, adding ADCs to dealnews2025-01-07T16:10:10+00:00January 7th, 2025|Endpoints News|
Profluent debuts AI model for CRISPR gene editing designnews2025-01-07T12:00:48+00:00January 7th, 2025|Endpoints News|
Exclusive: AI biotech Iambic snags CFO who helped steer Recursion-Exscientia dealnews2025-01-06T11:30:05+00:00January 6th, 2025|Endpoints News|
Ex-Color Health execs raise $10M to bring AI to pharmanews2024-12-19T12:00:18+00:00December 19th, 2024|Endpoints News|
Exclusive: Insitro finds new ALS drug target in Bristol Myers dealnews2024-12-18T12:00:57+00:00December 18th, 2024|Endpoints News|
Isomorphic Labs CEO Demis Hassabis bets on biotech’s AI futurenews2024-12-12T15:00:00+00:00December 12th, 2024|Endpoints News|
Relation and GSK to collaborate on fibrosis, osteoarthritisnews2024-12-10T00:00:37+00:00December 10th, 2024|Endpoints News|
Vijay Pande hands a16z biotech leadership to Vineeta Agarwalanews2024-12-09T18:49:46+00:00December 9th, 2024|Endpoints News|
Dimension nabs $500M second fund for ‘still contrary’ intersection of bio and machine learningnews2024-12-09T13:00:23+00:00December 9th, 2024|Endpoints News|
